LENZ THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LENZ THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $26.07M.
- LENZ THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $29.69M.
- LENZ THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $49.84M.
- LENZ THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $147.75M, a 85.82% increase from fiscal 2024.
- LENZ THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $79.51M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $147.75M 10-K · filed 2026-03-24 | |
| 2025-06-30 | $26.07M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $79.51M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $29.69M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $49.84M 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |